DNMT3B and gastric cancer: In summary, we find polymorphisms of DNMT3b may affect the overall survival of gastric cancer, suggesting the potential of DNMT3b SNPs as a useful marker to predict overall survival of gastric cancer, especially in patients surviving longer than two years.